(Q43281503)

18 November 2017

title

Improving insulin resistance with traditional Chinese medicine in type 2 diabetic patients (English)

1 reference

traditional Chinese medicine

18 November 2017

1 reference

1 reference

1 reference

object named as

traditional Chinese medicine

17 February 2024

Menglei Chao

1

1 reference

18 November 2017

Dajin Zou

2

1 reference

18 November 2017

Yifei Zhang

3

1 reference

18 November 2017

Yuhong Chen

4

1 reference

18 November 2017

Miao Wang

5

1 reference

18 November 2017

Hong Wu

6

1 reference

18 November 2017

Guang Ning

7

1 reference

18 November 2017

Weiqing Wang

8

1 reference

18 November 2017

publication date

1 October 2009

1 reference

18 November 2017

1 reference

18 November 2017

volume

36

1 reference

18 November 2017

issue

2

1 reference

18 November 2017

page(s)

268-274

1 reference

https://scigraph.springernature.com/pub.10.1007/s12020-009-9222-y

18 November 2017

exact match

0 references

cites work

Berberine stimulates glucose transport through a mechanism distinct from insulin.

1 reference

12 December 2020

Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects

1 reference

12 December 2020

Metabolic Syndrome: prevalence and prediction of mortality in elderly individuals

1 reference

12 December 2020

Randomized study of glibenclamide versus traditional Chinese treatment in type 2 diabetic patients. Chinese-French Scientific Committee for the Study of Diabetes.

1 reference

12 December 2020

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

12 December 2020

The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption

1 reference

12 December 2020

Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins

1 reference

12 December 2020

Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine

1 reference

12 December 2020

Novel insulin sensitivity index derived from oral glucose tolerance test

1 reference

12 December 2020

Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action

1 reference

12 December 2020

Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome.

1 reference

12 December 2020

Effects of berberine on glucose metabolism in vitro

1 reference

12 December 2020

Glucose clamp technique: a method for quantifying insulin secretion and resistance

1 reference

12 December 2020

Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states

1 reference

12 December 2020

Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence

1 reference

12 December 2020

10.1007/S12020-009-9222-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

18 November 2017

1004559318

0 references

1 reference